Silence Therapeutics(DE:XRP2)
€17.800.00 (0.00%)
DE:XRP2
Silence Therapeutics financials statements
€17.80
At close:0.00 (0.00%)
Silence Therapeutics (XRP2) Income Statement
37 Followers
Silence Therapeutics Income Statement
Last quarter (Q3 2026), Silence Therapeutics's total revenue was £0.00, a decrease of 100.00% from the same quarter last year. In Q3, Silence Therapeutics's net income was £-12.43M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 559.00K | £ 43.26M | £ 25.38M | £ 17.65M | £ 12.41M | |
| £ 344.00K | £ 31.45M | £ 15.06M | £ 6.68M | £ 4.96M | |
| £ 90.10M | £ 94.77M | £ 64.66M | £ 56.44M | £ 50.77M | |
| Depreciation and Amortization | £ 555.00K | £ 463.32K | £ 498.00K | £ 490.91K | £ 425.14K |
| £ -88.05M | £ -49.12M | £ -49.78M | £ -39.93M | ― | |
| £ -89.75M | £ -63.32M | £ -49.60M | £ -49.76M | £ -45.81M | |
| £ 1.15M | £ 18.86M | £ -706.00K | £ 9.29M | £ -42.00K | |
| £ -88.60M | £ -44.46M | £ -50.31M | £ -40.47M | £ -45.86M | |
| £ -88.61M | £ -45.31M | £ -43.27M | £ -41.03M | £ -39.41M | |
| Per Share Metrics | |||||
| Basic EPS | £ -5.67 | £ -2.37 | £ -3.48 | £ -3.78 | £ -1.35 |
| Diluted EPS | £ -5.67 | £ -2.37 | £ -3.48 | £ -3.78 | £ -1.35 |
| Weighted Average Shares Outstanding | 15.74M | 15.42M | 12.36M | 10.73M | 29.65M |
| Weighted Average Shares Outstanding (Diluted) | 15.74M | 15.42M | 12.36M | 10.73M | 29.65M |
Currency in GBP

